NMPA Approval

Remifentanil Hydrochloride for Injection

Approval Number

国药准字H20123422

Company国药集团工业有限公司廊坊分公司

Registration Date

July 28, 2022

Previous Approval Numbers

国药准字H20123422

Drug Information

Generic Name

注射用盐酸瑞芬太尼

Dosage Form

注射剂

Strength

1mg(按C₂₀H₂₈N₂O₅计)

Drug Type

化学药品

Registration Date

July 28, 2022

Company Information

Applicant Company

Company Name国药集团工业有限公司廊坊分公司

Company Address

廊坊经济技术开发区创业路

Manufacturing Company

Company Name国药集团工业有限公司廊坊分公司

Company Address

廊坊经济技术开发区创业路

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

注射用盐酸瑞芬太尼 - NMPA 批准文号 | MedPath